Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: An analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light

Transfusion

Volumn 46, Issue 1, 2006, Pages 24-33

  Murphy, Scott ^b   Snyder, Edward ^b   Cable, Ritchard ^b   Slichter, Sherrill J ^b   Strauss, Ronald G ^b   McCullough, Jeffrey ^b   Lin, Jin Sying ^b   Corash, Laurence ^b   Conlan, Maureen G ^a  

^a CERUS CORPORATION   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD3 ANTIGEN; CESIUM 137; COBALT 60; POLYSTYRENE; PSORALEN DERIVATIVE; S 59, PSORALEN; S-59, PSORALEN;

ARTICLE; BLOOD RADIATION; CELL GROWTH; DOSIMETRY; ERYTHROCYTE; FLOW CYTOMETRY; GAMMA RADIATION; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PHANTOM; RADIATION DOSE DISTRIBUTION; RADIOSENSITIVITY; T LYMPHOCYTE; TEMPERATURE; X RAY; ADULT; BLEEDING; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; MALE; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; PHOTOTHERAPY; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA;

ADULT; FEMALE; HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; PLATELET TRANSFUSION; PSORALENS; THROMBOCYTOPENIA; ULTRAVIOLET THERAPY;

EID: 33644841313     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2005.00671.x     Document Type: Article

References (22)

1. Klein HG Will blood transfusion ever be safe enough? JAMA 2000 284 238 40
2. Aubuchon JP Birkmeyer JD Busch MP Safety of the blood supply in the United States: opportunities and controversies Ann Intern Med 1997 127 905 9
3. Busch MP Chamberland M Epstein J et al. Oversight and monitoring of blood safety in the United States Vox Sang 1999 77 67 76
4. Luban NL Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components Semin Hematol 2001 38 Suppl 11 34 45
5. Blajchman MA Goldman M Baeza F Improving the bacteriological safety of platelet transfusions Transfus Med Rev 2004 18 11 24
6. Goldman M Blajchman MA Blood-product associated bacterial sepsis Transfus Med Rev 1991 5 73 83
7. Wollowitz S Fundamentals of the psoralen-based Helinx technology for inactivation of infectious pathogens and leukocytes in platelets and plasma Semin Hematol 2001 38 4 11
8. Lin L Psoralen photochemical treatment of platelets Sci Med 1994 5 2 11
9. Lin L Cook DN Wiesehahn G et al. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light Transfusion 1997 37 423 35
10. Lin L Alfonso R Behrman B et al. Photochemical treatment of platelet concentrates with a novel psoralen and UVA to enhance the safety of platelet transfusion Infus Ther Transfus Med 1998 39 48
11. Grass JA Hei DJ Metchette K et al. Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA Blood 1998 91 2180 8
12. 111indium-radiolabeled platelets treated with pathogen inactivation with amotosalen HCl (S-59) and ultraviolet A light Transfusion 2004 44 1732 40
13. Slichter SJ Raife TJ Davis K et al. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in thrombocytopenic patients Transfusion in press
14. VanRhenen D Gulliksson H Cazenave JP et al. Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial Blood 2003 101 2426 533
15. Janetzko K Cazenave JP Kluter H et al. Therapeutic efficacy and safety of photochemically treated platelets processed with an optomized integrated set Transfusion 2005 45:1443 52
16. McCullough J Vesole DH Benjamin RJ et al. Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT trial Blood 2004 104 1534 41
17. Standards for blood banks and transfusion services 22nd ed. Bethesda American Association of Blood Banks; 2003
18. Guideline for the collection of platelets, pheresis prepared by automated methods [monograph on the Internet] Rockville (MD) Center for Biologics Evaluation and Research (CBER), Food and Drug Administration; 1988 Oct. Available from:
19. Grass JA Wafa T Reames A et al. Prevention of transfusion-associated graft-versus-host disease by photochemical treatment Blood 1999 93 3140 7
20. Nash R Gooley T Davis C Appelbaum F The problem of thrombocytopenia after hematopoietic stem cell transplantation Stem Cells 1996 14 Suppl 1 261 73
21. Schmitz N Linch D Dreger P et al. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients Lancet 1996 347 353 7
22. Smith T Hillner B Schmitz N et al. Economic analysis of a randomized clinical trial to compare filgrastim-mobilized peripheral-blood progenitor-cell transplantation and autologous bone marrow transplantation in patients with Hodgkin's and non-Hodgkin's lymphoma J Clin Oncol 1997 15 5 10